Magellan Health (MGLN) Posts Q3 EPS of $1.31, Beats Views; Increases FY10 EPS Outlook
Tweet Send to a FriendGet Alerts MGLN Hot Sheet
Price: $51.70 +1.75%
EPS Growth %: +34.7%
Financial Fact:
Provision for income taxes: 19.11M
Today's EPS Names:
LBIX, ESEA, ISS, More
EPS Growth %: +34.7%
Financial Fact:
Provision for income taxes: 19.11M
Today's EPS Names:
LBIX, ESEA, ISS, More
Trade MGLN Now!
Magellan Health (Nasdaq: MGLN) reports Q3 EPS of $1.31, versus the analyst estimate of $0.91. Revenue for the quarter was $750.3 million, which compares to the estimate of $756.02 million.
Increases FY10 EPS outlook to a range of $3.66 - $4.07, compared to the consensus of $3.66.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Increases FY10 EPS outlook to a range of $3.66 - $4.07, compared to the consensus of $3.66.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Applied Materials, Inc. (AMAT) Tops Q2 EPS by 3c, Offers Guidance
- ReneSola Ltd. (SOL) Posts Q1 Loss of 45c/ADS; Guides Q2, FY13 Shipments
- 21Vianet Group (VNET) Misses Q1 EPS by 4c
Create E-mail Alert Related Categories
Earnings, Guidance
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
